loading page

Clinical Magnet Application to Temporarily Inhibit Subcutaneous Implantable Cardioverter Defibrillators Therapy in Emergency Situations: One size fits all.
  • +8
  • Maurizio Santomauro,
  • Mario Petretta,
  • francesco cacciatore,
  • carla riganti,
  • andrea santomauro,
  • Gaetano Castellano,
  • Aniello Viggiano,
  • gianluigi iovino,
  • Antonio Rapacciuolo,
  • Francesco Mafettone,
  • Pasquale Abete
Maurizio Santomauro
Federico II University
Author Profile
Mario Petretta
University of Naples Federico II
Author Profile
francesco cacciatore
University of Naples Federico II

Corresponding Author:[email protected]

Author Profile
carla riganti
University of Naples Federico II
Author Profile
andrea santomauro
University of Salerno
Author Profile
Gaetano Castellano
University of Salerno
Author Profile
Aniello Viggiano
University of Naples Federico II
Author Profile
gianluigi iovino
Federico II University
Author Profile
Antonio Rapacciuolo
Federico II University of Naples
Author Profile
Francesco Mafettone
University of Naples Federico II
Author Profile
Pasquale Abete
University of Naples Federico II
Author Profile

Abstract

The subcutaneous implantable cardioverter defibrillatoruse has increased worldwide. The annual rate of inappropriate shock (IAS) is between 3.1% and 25% and is usually followed by admission in Critical Care units. In such setting, the suspension of shock therapy is mandatory during an electrical storm. Temporary inhibition is also requested during surgical procedures but now is not yet clearly addressed by guidelines. Here we describe the strategies that can be followed to reduce IAS in critical care settings with the appropriate use of any model of clinical magnet, to temporarily inhibit shock therapies.